Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This study is testing whether adding a medication called ganagliflozin to standard treatment can help slow the worsening of kidney disease in people who have both type 2 diabetes and chronic kidney disease. About 1,244 participants will take either ganagliflozin or a placebo (ina…

This study aims to see if a new drug called HDM1005 works as well or better than an existing drug called mazdutide for controlling blood sugar in adults with type 2 diabetes. It will involve about 912 people whose diabetes is not well-managed with their current metformin-based tr…